AngioLab (XKRX:251280) FCF Margin % : -173.04% (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is AngioLab FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. AngioLab's Free Cash Flow for the six months ended in Dec. 2023 was ₩-859.4 Mil. AngioLab's Revenue for the six months ended in Dec. 2023 was ₩496.6 Mil. Therefore, AngioLab's FCF Margin % for the quarter that ended in Dec. 2023 was -173.04%.

As of today, AngioLab's current FCF Yield % is -5.35%.

The historical rank and industry rank for AngioLab's FCF Margin % or its related term are showing as below:

XKRX:251280' s FCF Margin % Range Over the Past 10 Years
Min: -1382.71 Med: -183.79 Max: -17.24
Current: -173.04

During the past 7 years, the highest FCF Margin % of AngioLab was -17.24%. The lowest was -1382.71%. And the median was -183.79%.

XKRX:251280's FCF Margin % is ranked worse than
52.55% of 1041 companies
in the Biotechnology industry
Industry Median: -141.21 vs XKRX:251280: -173.04

AngioLab FCF Margin % Historical Data

The historical data trend for AngioLab's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioLab FCF Margin % Chart

AngioLab Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-234.45

-1,382.71

-211.35

-183.79

-173.04

AngioLab Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
FCF Margin %	Get a 7-Day Free Trial			-234.45	-1,382.71	-211.35	-183.79	-173.04

Competitive Comparison of AngioLab's FCF Margin %

For the Biotechnology subindustry, AngioLab's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AngioLab's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AngioLab's FCF Margin % distribution charts can be found below:

* The bar in red indicates where AngioLab's FCF Margin % falls into.

AngioLab FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

AngioLab's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-859.398	/	496.646
	=	-173.04 %

AngioLab's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-859.398	/	496.646
	=	-173.04 %

AngioLab FCF Margin % Related Terms

Thank you for viewing the detailed overview of AngioLab's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

AngioLab (XKRX:251280) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN

Website

http://www.angiolab.co.kr

AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.

AngioLab (XKRX:251280) Headlines

No Headlines